本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

17.64
-0.0800-0.45%
盤後17.59-0.0500-0.28%18:12 EDT
成交量:166.21萬
成交額:2,940.34萬
市值:22.55億
市盈率:102.32
高:17.98
開:17.62
低:17.48
收:17.72
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.54
換手率:2.13%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:6.09
市盈率(LYR):102.32

資料載入中...

2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities